The global preclinical medical device testing services market is valued at USD 4.30 billion in 2026 and is projected to reach about USD 9.60 billion by 2035, growing at a 9.2% CAGR from 2026 to 2035 (2025 market size USD 3.96 billion). Growth is driven by rising R&D, the need to demonstrate safety and effectiveness for more complex devices, and strict regulations.

Market Snapshot

  • Revenue, 2026: 4.30 Billion
  • Forecast, 2035: 9.60 Billion
  • CAGR, 2026-2035: 9.2%
  • Report Coverage: Global

Key Companies

  • SGS SA
  • Eurofins Scientific
  • Pace Analytical Services LLC
  • Intertek Group Plc
  • WUXI APPTEC
  • TÜV SÜD AG
  • Sterigenics International LLC
  • Nelson Labs
  • North American Science Associates Inc.
  • Charles River Laboratories International Inc.

About Healthcare Foresights

Healthcare Foresights provides market research and consulting across the healthcare and life sciences industry, combining industry research, analytical expertise and technology-enabled solutions to help companies, investors and decision-makers identify opportunities and drive growth. For the full report, customization or a sample, contact our team.